Q-Line Biotech Limited (NSE:QLINE)
India · Delayed Price · Currency is INR 562.60
+36.75 (6.99%)
At close: Jun 19, 2026
Q-Line Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 764.37 | 470.26 | 299.56 | 900.19 | 465.37 |
Short-Term Investments | - | - | - | - | 75.72 |
Cash & Short-Term Investments | 764.37 | 470.26 | 299.56 | 900.19 | 541.1 |
Cash Growth | 62.54% | 56.98% | -66.72% | 66.36% | 1861.13% |
Accounts Receivable | 1,258 | 826.03 | 264.44 | 330.58 | 430.35 |
Other Receivables | - | 120 | - | - | 19.89 |
Receivables | 1,624 | 946.17 | 264.44 | 330.58 | 450.25 |
Inventory | 949.6 | 902.13 | 1,052 | 435.94 | 376.26 |
Prepaid Expenses | - | 5.2 | 5.11 | 1.68 | 1.93 |
Other Current Assets | 102.63 | 322.62 | 363.8 | 92.71 | 391.95 |
Total Current Assets | 3,441 | 2,646 | 1,985 | 1,761 | 1,761 |
Property, Plant & Equipment | 1,340 | 1,125 | 740.43 | 344.6 | 94 |
Long-Term Investments | 166.74 | 0 | 285.11 | 157.04 | - |
Goodwill | 2.69 | 2.69 | - | - | - |
Other Intangible Assets | 266.4 | 46.34 | 12.59 | 0.81 | - |
Long-Term Deferred Tax Assets | 10.63 | 9.81 | 5.78 | 7.07 | 1.47 |
Long-Term Deferred Charges | - | 187.83 | 37.92 | - | - |
Other Long-Term Assets | 305.35 | 532.66 | 315.39 | 235.59 | 12.51 |
Total Assets | 5,587 | 4,555 | 3,392 | 2,516 | 1,920 |
Accounts Payable | 520.43 | 556.25 | 592.38 | 397.06 | 346.61 |
Accrued Expenses | - | 195.91 | 98.36 | 53.28 | 16.46 |
Short-Term Debt | 1,293 | 554.61 | 504.02 | 541.7 | 334.18 |
Current Portion of Long-Term Debt | - | 270.77 | 114.15 | 51.72 | - |
Current Portion of Leases | - | 13.45 | - | - | - |
Current Income Taxes Payable | - | 141.22 | 23.55 | 27.87 | 62.95 |
Current Unearned Revenue | - | 36.98 | 6.72 | 5.03 | - |
Other Current Liabilities | 285.83 | 22.25 | 63.6 | 4.85 | 39.42 |
Total Current Liabilities | 2,099 | 1,791 | 1,403 | 1,081 | 799.61 |
Long-Term Debt | 961.92 | 824.12 | 350.93 | 143.07 | 100.13 |
Pension & Post-Retirement Benefits | - | 26.18 | 18.58 | 16.58 | - |
Other Long-Term Liabilities | 63.85 | 13.68 | 2.03 | 1 | 0 |
Total Liabilities | 3,125 | 2,655 | 1,774 | 1,242 | 899.75 |
Common Stock | 162.75 | 15.75 | 15.75 | 15.75 | 15.75 |
Additional Paid-In Capital | - | 13.01 | 13.01 | 13.01 | - |
Retained Earnings | - | 1,871 | 1,589 | 1,245 | - |
Comprehensive Income & Other | 2,299 | - | - | - | 1,004 |
Shareholders' Equity | 2,462 | 1,899 | 1,618 | 1,274 | 1,020 |
Total Liabilities & Equity | 5,587 | 4,555 | 3,392 | 2,516 | 1,920 |
Total Debt | 2,255 | 1,663 | 969.1 | 736.48 | 434.32 |
Net Cash (Debt) | -1,490 | -1,193 | -669.54 | 163.71 | 106.78 |
Net Cash Growth | - | - | - | 53.31% | - |
Net Cash Per Share | -93.06 | -75.73 | -42.51 | 10.39 | 7.12 |
Filing Date Shares Outstanding | 14.83 | 16.27 | 15.75 | 15.75 | 15.75 |
Total Common Shares Outstanding | 14.83 | 16.27 | 15.75 | 15.75 | 15.75 |
Working Capital | 1,341 | 854.95 | 582.54 | 679.61 | 961.86 |
Book Value Per Share | 166.06 | 116.71 | 102.74 | 80.87 | 64.76 |
Tangible Book Value | 2,193 | 1,850 | 1,606 | 1,273 | 1,020 |
Tangible Book Value Per Share | 147.91 | 113.70 | 101.94 | 80.82 | 64.76 |
Land | - | 203.51 | 201.41 | 123.74 | - |
Buildings | - | 153.08 | 148.94 | 32.3 | - |
Machinery | - | 369.65 | 323.98 | 158.44 | - |
Construction In Progress | - | 590.31 | 191.72 | 117.37 | - |